Additional file 3 of Efficacy and safety of Tripterygium wilfordii polyglycosides for diabetic kidney disease: an overview of systematic reviews and meta-analyses

Additional file 3: Supplemental Table 1. Overview of 24-hour Urinary Protein in the Included SRs and MAs. Supplemental Table 2. Overview of the Included SRs and MAs of Renal Function. Supplemental Table 3. Overview of the Included SRs and MAs about the Outcome of Serum Albumin. Supplemental Table 4. Overview of the Included SRs and MAs of AL. Supplemental Table 5. Overview of the included SRs and MAs about the outcomes of WBC. Supplemental Table 6. Overview of the Incidence of Adverse Events in the Included SRs and MAs. Supplemental Table 7. Methodological Quality Assessment of the Systematic Reviews and Meta-analyses Based on AMSTAR-2 tool. Supplemental Table 8. Quality of Evidence in Included SRs with GRADE.